Journal for ImmunoTherapy of Cancer (Nov 2023)

1449 NCG-M is a triple immunodeficient mouse with increased reconstitution of human myeloid cell populations for use in immunotherapy preclinical research

  • Christoph Eberle,
  • Jenny Rowe,
  • Ann Fiore,
  • Robert Mihalek,
  • Stephen Festin,
  • Steven Bronson

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.1449
Journal volume & issue
Vol. 11, no. Suppl 1

Abstract

Read online

No abstracts available.